These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25782323)

  • 1. [Compliance to treatment and effectiveness of therapy in different regimes of monitoring activity of patients with axial spondyloarthritis].
    Gaĭdukova IZ; Akulova AI; Aparkina AV; Rebrov AP
    Klin Med (Mosk); 2014; 92(10):60-5. PubMed ID: 25782323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network.
    Che H; Etcheto A; Dernis E; Nataf H; Boumier P; Breuillard P; Durandin-Truffinet M; Fechtenbaum J; Gaud-Listrat V; Giraud B; Hudry C; Labatide-Alanore S; Le Devic P; Le Goux P; Lebrun A; Maheu E; Moura B; Nguyen M; Sacchi A; Ayral X; Blanchais A; Neveu S; Dougados M; Moltó A
    Clin Exp Rheumatol; 2015; 33(6):851-7. PubMed ID: 26411931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flare in spondyloarthritis: Thresholds of disease activity variations.
    Godfrin-Valnet M; Puyraveau M; Prati C; Wendling D
    Joint Bone Spine; 2015 May; 82(3):192-5. PubMed ID: 25619155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADVANTAGES OF REMOTE MONITORING THE ACTIVITY OF PATIENTS WITH AXIAL SPONDYLITIS (PROGRESS STUDY).
    Gaidukova IZ; Akulova AI; Aparkina AV; Rebrov AP
    Klin Med (Mosk); 2016; 94(4):279-285. PubMed ID: 28957607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
    Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
    Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.
    Sieper J; Srinivasan S; Zamani O; Mielants H; Choquette D; Pavelka K; Loft AG; Géher P; Danda D; Reitblat T; Cantini F; Ancuta C; Erdes S; Raffayová H; Keat A; Gaston JS; Praprotnik S; Vastesaeger N
    Ann Rheum Dis; 2013 Oct; 72(10):1621-7. PubMed ID: 23065731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.
    Gremese E; Bernardi S; Bonazza S; Nowik M; Peluso G; Massara A; Tolusso B; Messuti L; Miceli MC; Zoli A; Trotta F; Govoni M; Ferraccioli G
    Rheumatology (Oxford); 2014 May; 53(5):875-81. PubMed ID: 24407233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
    Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
    Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China.
    Xu M; Lin Z; Deng X; Li L; Wei Y; Liao Z; Li Q; Wei Q; Hu Z; Zhang Y; Lin Q; Huang J; Li T; Pan Y; Wu Y; Jin O; Yu B; Gu J
    Rheumatology (Oxford); 2011 Aug; 50(8):1466-72. PubMed ID: 21441550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis.
    Paramarta JE; De Rycke L; Heijda TF; Ambarus CA; Vos K; Dinant HJ; Tak PP; Baeten DL
    Ann Rheum Dis; 2013 Nov; 72(11):1793-9. PubMed ID: 23139265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care.
    Poddubnyy D; Vahldiek J; Spiller I; Buss B; Listing J; Rudwaleit M; Sieper J
    J Rheumatol; 2011 Nov; 38(11):2452-60. PubMed ID: 21921100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort.
    Tournadre A; Pereira B; Lhoste A; Dubost JJ; Ristori JM; Claudepierre P; Dougados M; Soubrier M
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1482-9. PubMed ID: 23463610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.
    Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Kalstad S; Kvien TK
    Rheumatology (Oxford); 2012 Aug; 51(8):1479-83. PubMed ID: 22499062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with spondyloarthritis are equally satisfied with follow-up by physiotherapist and rheumatologist.
    Holøyen PK; Stensdotter AK
    Musculoskeletal Care; 2018 Sep; 16(3):388-397. PubMed ID: 29573538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.
    Gulfe A; Kapetanovic MC; Kristensen LE
    Scand J Rheumatol; 2014; 43(6):493-7. PubMed ID: 25145283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis.
    Braun J; Inman R
    Ann Rheum Dis; 2010 Jul; 69(7):1264-8. PubMed ID: 20566619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.
    Kroon F; Landewé R; Dougados M; van der Heijde D
    Ann Rheum Dis; 2012 Oct; 71(10):1623-9. PubMed ID: 22532639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis.
    de Andrade KR; de Castro GR; Vicente G; da Rosa JS; Nader M; Pereira IA; Fröde TS
    Int Immunopharmacol; 2014 Aug; 21(2):481-6. PubMed ID: 24925756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.